Concepedia

Tibor Balázs

TB

Statistics

Publications

61

Citations

3.1K

H-Index

26

Active since

1959

Affiliations

United States Food and Drug Administration(Current)

National Heart Lung and Blood Institute

Tibor Balázs is an author at United States Food and Drug Administration specializing in pharmacology, medicine, and cardiology.

Publications per year

1959–2018

61

Publications

61

An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat.

G Róna, Chappel Ci, Tibor Balázs et al. · PubMed · 1959 · 684 citations

Medicine, Pharmacology, Toxicology +13

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Désirée van der Heijde, James Cheng‐Chung Wei, Maxime Dougados et al. · The Lancet · 2018 · 359 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Long-Term Isolation Stress in Rats

Anita Hatch, Günnar Wiberg, Tibor Balázs et al. · Science · 1963 · 229 citations

Veterinary Medicine, Endocrinology, Neuroscience +17

Modulation by S–Adenosyl–L–Methionine of Hepatic Na+, K+–Atpase, Membrane Fluidity, and Bile Flow in Rats With Ethinyl Estradiol–Induced Cholestasis

Urs A. Boelsterli, Gopa Rakhit, Tibor Balázs · Hepatology · 1983 · 127 citations

Life Sciences, Biochemistry, Pharmacology +17

The influence of excess body fat on the cardiotoxicity of isoproterenol in rats

Tibor Balázs, M. R. Sahasrabudhe, H. C. Grice · Toxicology and Applied Pharmacology · 1962 · 114 citations

Medicine, Pharmacology, Physiology +12

1–5 of 61